Cai Y - Search Results

1

RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas.

Konstantinidou G, Ramadori G, Torti F, Kangasniemi K, Ramirez RE, Cai Y, Behrens C, Dellinger MT, Brekken RA, Wistuba II, Heguy A, Teruya-Feldstein J, Scaglioni PP. Konstantinidou G, et al. Among authors: cai y. Cancer Discov. 2013 Apr;3(4):444-57. doi: 10.1158/2159-8290.CD-12-0388. Epub 2013 Jan 28. Cancer Discov. 2013. PMID: 23358651 Free PMC article.

2

Analysis of clinical characteristics and prognosis of patients with anaplastic lymphoma kinase-positive and surgically resected lung adenocarcinoma.

Tao H, Cai Y, Shi L, Tang J, Liu Z, Wang Z, Bai L, Liu Z. Tao H, et al. Among authors: cai y. Thorac Cancer. 2017 Jan;8(1):8-15. doi: 10.1111/1759-7714.12395. Epub 2016 Oct 24. Thorac Cancer. 2017. PMID: 27779369 Free PMC article.

3

Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression.

Cai Y, Wu H, Shi X, Dong Y, Chang X, Zhang L, Zhou L, Su D, Yang M. Cai Y, et al. BMC Cancer. 2020 Feb 24;20(1):148. doi: 10.1186/s12885-020-6631-z. BMC Cancer. 2020. PMID: 32093629 Free PMC article.

4

Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer.

Xu J, Wan R, Cai Y, Cai S, Wu L, Li B, Duan J, Cheng Y, Li X, Wang X, Han L, Wu X, Fan Y, Yu Y, Lv D, Shi J, Huang J, Zhou S, Han B, Sun G, Guo Q, Ji Y, Zhu X, Hu S, Zhang W, Wang Q, Jia Y, Wang Z, Song Y, Wu J, Shi M, Li X, Han Z, Liu Y, Yu Z, Liu AW, Wang X, Zhou C, Zhong D, Miao L, Zhang Z, Zhao H, Yang J, Wang D, Wang Y, Li Q, Zhang X, Ji M, Yang Z, Cui J, Gao B, Wang B, Liu H, Nie L, He M, Jin S, Gu W, Shu Y, Zhou T, Feng J, Yang X, Huang C, Zhu B, Yao Y, Yu J, Yao S, Shen R, Wang Z, Wang J. Xu J, et al. Among authors: cai y, cai s. Cancer Cell. 2024 Sep 9;42(9):1598-1613.e4. doi: 10.1016/j.ccell.2024.08.013. Cancer Cell. 2024. PMID: 39255777 Free article.

5

Increased blood-based intratumor heterogeneity (bITH) is associated with unfavorable outcomes of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer.

Zhou J, Bao M, Gao G, Cai Y, Wu L, Lei L, Zhao J, Ji X, Huang Y, Su C. Zhou J, et al. Among authors: cai y. BMC Med. 2022 Jul 29;20(1):256. doi: 10.1186/s12916-022-02444-8. BMC Med. 2022. PMID: 35902848 Free PMC article.

6

Clinicopathologic characteristics of ALK rearrangements in primary lung adenocarcinoma with identified EGFR and KRAS status.

Wang J, Dong Y, Cai Y, Zhou L, Wu S, Liu G, Su D, Li X, Qin N, Nong J, Jia H, Zhang Q, Mu J, Zeng X, Zhang H, Zhang S, Zhang Z. Wang J, et al. Among authors: cai y. J Cancer Res Clin Oncol. 2014 Mar;140(3):453-60. doi: 10.1007/s00432-014-1584-8. Epub 2014 Jan 18. J Cancer Res Clin Oncol. 2014. PMID: 24442099

7

ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors.

Nie W, Wang ZJ, Zhang K, Li B, Cai YR, Wen FC, Zhang D, Bai YZ, Zhang XY, Wang SY, Cheng L, Zhong H, Liu L, Wang J, Han BH. Nie W, et al. BMC Med. 2022 May 5;20(1):170. doi: 10.1186/s12916-022-02360-x. BMC Med. 2022. PMID: 35509036 Free PMC article.

8

Topoisomerase I expression is associated with prognosis in postoperative non-small cell lung cancer patients.

Lu B, Zhang H, Zhang T, Cai Y, Hu Y, Zheng H, Li B. Lu B, et al. Among authors: cai y. Thorac Cancer. 2016 Jul;7(4):486-94. doi: 10.1111/1759-7714.12359. Epub 2016 May 11. Thorac Cancer. 2016. PMID: 27385993 Free PMC article.

9

MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines.

Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, Liu Z. Tian Y, et al. Among authors: cai y. J Biol Chem. 2010 Mar 12;285(11):7986-94. doi: 10.1074/jbc.M109.062877. Epub 2010 Jan 14. J Biol Chem. 2010. PMID: 20075075 Free PMC article.

10

Expression of MET and SOX2 genes in non-small cell lung carcinoma with EGFR mutation.

Cai YR, Zhang HQ, Qu Y, Mu J, Zhao D, Zhou LJ, Yan H, Ye JW, Liu Y. Cai YR, et al. Oncol Rep. 2011 Oct;26(4):877-85. doi: 10.3892/or.2011.1349. Epub 2011 Jun 15. Oncol Rep. 2011. PMID: 21687954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,947 results

Search Page